Meeting on the Mesa 2021 | Addressing the regulatory barriers advanced therapies face

Christian Schneider, MD, Biopharma Excellence, Munich, Germany, addresses the regulatory challenges advanced therapy manufacturers face. Existing regulatory guidelines may not be sufficiently detailed for developers from a scientific perspective and Dr Schneider emphasizes the need for a personalized approach by working with regulators early on to adapt current guidelines for the specific needs of new products. This interview took place at Meeting on the Mesa 2021.